इसराइल - हिब्रू - Ministry of Health

abbott medical laboratories ltd - ascorbic acid 65 mg / 100 ml; biotin 57.6 mcg / 100 ml - liquid - fat/carbohydrates/proteins/minerals/vitamins, combinations - ready to use, high - nitrogen isotonic liquid nutrition.

इसराइल - हिब्रू - Ministry of Health

vitamed pharmaceutical industries ltd - dipyrone - סירופ - dipyrone 1.25 g / 5 ml - pyrazolones - relief of moderate to severe pain as in headache, toothache, dysmenorrhea andfor high fever that does not respond to other measures.

इसराइल - हिब्रू - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin (prn or 69 kda omp); pertussis toxoid vaccine; tetanus toxoid - תרחיף להזרקה - pertactin (prn or 69 kda omp) 2.5 mcg / 0.5 ml; diphtheria toxoid nlt 2 iu / 0.5 ml; tetanus toxoid nlt 20 iu / 0.5 ml; filamentous haemagglutinin (fha) 8 mcg / 0.5 ml; pertussis toxoid vaccine 8 mcg / 0.5 ml; inactivated polio virus (ipv) type 3 32 du / 0.5 ml; inactivated polio virus (ipv) type 1 40 du / 0.5 ml; inactivated polio virus (ipv) type 2 8 du / 0.5 ml - bacterial and viral vaccines, combined - for booster vaccination against diphtheria, tetanus and pertusis and poliomyelitis of individuals from the age of four years onwards. boostrix polio is not intended for primary immunisation. the administration of boostrix polio should be based on official recommendations.

इसराइल - हिब्रू - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

इसराइल - हिब्रू - Ministry of Health

אנ.בי.סי. חביבה ריבקין בעמ - טיפוח עור הפנים

इसराइल - हिब्रू - Ministry of Health

אינטרביוטי קוסמטיקס ישראל בעמ - חפיפת שיער

इसराइल - हिब्रू - Ministry of Health

גדעון קוסמטיקס בעמ - לשיקום הזנה וברק לשיער צבוע,יבש ופגום

इसराइल - हिब्रू - Ministry of Health

אינטרביוטי קוסמטיקס ישראל בעמ - שיפור מראה העור

इसराइल - हिब्रू - Ministry of Health

בירנפלד יפה - שיפור מראה העור

इसराइल - हिब्रू - Ministry of Health

אודיה תעשיות בעמ - מיצוק העור